Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms


COVID-19, coronavirus
3D print of a spike protein of SARS-CoV-2, the virus that causes COVID-19–in front of a 3D print of a SARS-CoV-2 virus particle. The spike protein (foreground) enables the virus to enter and infect human cells. On the virus model, the virus surface (blue) is covered with spike proteins (red) that enable the virus to enter and infect human cells. Credit: NIH

For some COVID-19 patients, the body’s immune response may be as destructive as the virus that causes the disease. The persistent high fevers, severe respiratory distress, and lung damage seen in some critically ill patients are all signs of an immune system in overdrive.

Now, a new clinical trial will test a treatment that targets this overactive , says Howard Hughes Medical Investigator Bert Vogelstein. He and his team at the Johns Hopkins University School of Medicine are currently recruiting individuals for the trial, which includes patients ages 45 to 85 at the Johns Hopkins Hospital who have COVID-19 but who aren’t on a ventilator or in the ICU.

Their treatment, a common type of prescription drug called an alpha blocker, might break a cycle of hyperinflammation before it ramps up, their findings from mouse studies and a recent analysis of medical claims data suggest.

“The approach we’re advocating involves treating people who are at high risk early in the course of the disease, when you know they’re infected but before they have severe symptoms,” says Vogelstein. If the trial’s results suggest the drug is safe and effective against COVID-19, it could potentially help many people recover safely at home and lessen the strain on hospital resources, he says.

Runaway reaction

A hyperactive immune response isn’t unique to COVID-19. People with autoimmune diseases and receiving immunotherapy can experience similar symptoms. These responses are referred to as macrophage activation syndrome, —or simply “ storms.”

When macrophages (and some other kinds of immune cells) detect virus particles, they send out alert messages by releasing various proteins known as cytokines. Those cytokines recruit other immune cells to the scene—an inflammatory response that, in moderation, helps the body fight off a virus. But macrophages can also release other signaling molecules, called catecholamines, that amplify this response further, triggering the release of more cytokines. The result is a runaway feedback loop, like a snowball getting bigger as it barrels down a hill.

“It seems that once this process starts, there’s this inability to properly switch it off,” says Maximilian Konig, a rheumatologist at Hopkins who is helping to coordinate the trial.

Before COVID-19 hit, Vogelstein’s team was already exploring ways to ease the hyperinflammatory immune response in cancer patients treated with immunotherapy. The researchers were interested in drugs called alpha blockers, which are widely prescribed for prostate conditions and high blood pressure—and also interfere with the cell signaling that triggers cytokine storms. In theory, alpha blockers might stop a cytokine storm before it starts.

Giving mice with bacterial infections an alpha blocker lessened cytokine storms and decreased deaths, Vogelstein’s team reported in the journal Nature in 2018. And, the researchers found, the treatment didn’t seem to harm other aspects of the immune response.

Staving off the storm

As the COVID-19 pandemic escalated in the United States over the past few months and severely ill patients presented with cytokine storm symptoms, the idea of testing alpha blockers in humans has become more urgent, Vogelstein’s team recently argued in the Journal of Clinical Investigation.

To obtain approval for an alpha blocker clinical trial, Vogelstein’s team first surveyed medical claims data. They combed through records from people hospitalized for pneumonia and acute respiratory distress and analyzed whether patients’ outcomes were better if they had been taking alpha blockers for unrelated conditions. The team’s tentative conclusion: taking alpha blocker drugs correlated to a lower risk of death from respiratory distress.

On its own, that’s not strong enough evidence to prescribe the drug for a wholly new disease like COVID-19, says Susan Athey, an economist at Stanford University who collaborated with Vogelstein’s team on the claims analysis. But it helps bolster the case for the team’s clinical trial.

In the trial, COVID-19 patients will take gradually increasing doses of an alpha blocker called prazosin, sold under the brand name Minipress, over six days, says Chetan Bettegowda, a neurosurgeon at Hopkins who is helping to design and run the . Then, the team will evaluate whether people who received this treatment had a lower ICU admission rate or ventilator use than patients who received the standard treatment. They’ll follow each patient for 60 days, but preliminary data from the first patients could be available within weeks to months, Bettegowda says.

If the trial’s results suggest alpha blockers are safe and effective, the team hopes to run a second trial with patients who have been diagnosed with COVID-19 but are not yet hospitalized. They’re also encouraging colleagues at other hospitals to join their clinical trial efforts, to gather patient data more quickly.

This treatment, if it works, would be a secondary form of prevention, Vogelstein says, mitigating symptoms before they become severe, rather than stopping infection in the first place. “Eventually, hopefully, a vaccine will be produced, and that will be the essence of prevention,” he says. “But until vaccines are available, secondary prevention makes a lot of sense.”


Follow the latest news on the coronavirus (COVID-19) outbreak


More information:
Maximilian F. Konig et al, Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists, Journal of Clinical Investigation (2020). DOI: 10.1172/JCI139642

Citation:
Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms (2020, May 22)
retrieved 22 May 2020
from https://medicalxpress.com/news/2020-05-cytokine-storm-ease-severe-covid-.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



loading...

Related posts:

Using electrical stimulus to regulate genes
As COVID-19 stalls vacation, achieve travel's health benefits at home
WHO: Corona-Ansteckung durch Berührung von Oberflächen nicht bewiesen
Electronic health records fail to detect up to 33% of medication errors
Researchers find potential drug treatment targets for alcohol-related liver disease
Pregnant and lactating women with COVID-19: Scant clinical research
DGVS mahnt Rückkehr zur regulären Früherkennung an
Überlebensvorteil durch elektive Halsdissektion? - Biermann Medizin
Das Spülschwamm-Mikrobiom: Was dich nicht umbringt, macht dich härter!
Sedative drug in combination with opioids may be especially dangerous
Live poultry linked to Salmonella cases in 28 states
Leopoldina: Gesundheitssystem weiterentwickeln - Biermann Medizin
AI successfully used to identify different types of brain injuries
Neuartiges COVID-19-Schnelltestverfahren auf Basis innovativer DNA-Polymerasen entwickelt
'Hug glove' gives Canada family bit of normalcy in pandemic
COVID-19 könnte bei Kindern schwere Entzündungserkrankung verursachen
Coronavirus infections may lead to delirium and potentially PTSD
Common misunderstandings doctors confront about preventing pregnancy
Canada bans cruise ship visits until October
Study reveals 'extensive' financial links between leaders of US medical societies and industry
Outside US, top scientists steer debate away from politics
Aerobics may be a smart workout for your brain at any age
Abnormalities detected on brain MRI of COVID-19 patients in ICU
New urine testing method holds promise for kidney stone sufferers
Mayor says Mexico City will begin gradual reopening June 1
Genome study links DNA changes to the risks of specific breast cancer subtypes
Interdisziplinäre zentrale Ultraschalleinheit des UKL als Ausbildungsstätte anerkannt
Managing mental health with yoga
Spaniards aged six and above ordered to wear masks
PM Johnson says Britain could reopen stores on June 15
Hamster tests show masks reduce coronavirus spread: scientists
Balanceakt: Gleichzeitige Bekämpfung von COVID-19 und den großen Volkskrankheiten
How mindfulness can help amid the COVID-19 pandemic
Neue Erkenntnisse zur Wirkweise von Ketamin
Existing racial inequalities in death from COVID-19 will soar
No improvements seen in meeting AAP vitamin D intake guidelines
New studies reveal extent and risks of laughing gas and stimulant abuse among young people
California hospitals saw sharp drop in heart attacks during COVID-19 shutdown
Brazil surges to second in coronavirus cases worldwide
E-Zigaretten: Experten sind uneins über den Nutzen der E-Zigarette bei der Entwöhnung
Officials cite mistakes as CDC removes coronavirus guidance
Using telehealth to transition diabetes inpatients to virtual care during COVID-19
Sondererhebung in der Corona-Krise: Medizinklimaindex fällt auf -25,1
Voluntary collective isolation is best response to COVID-19 for indigenous populations
Binge drinkers beware, drunkorexia is calling
Prevalence of 'silent' COVID-19 infection may be much higher than thought
Göttingen: DFG verlängert Förderung des Sonderforschungsbereiches „Herzschwäche“
Produce-buying incentive program a win-win for Oregon consumers and farmers
New research into stem cell mutations could improve regenerative medicine
New York City 'on track' to begin reopening week of June 8: governor
Slovenia opens borders after declaring epidemic over
Debates rage in Britain as some children go back to school
As US, Europe reopen more, big nations see rising virus toll
Vaccine hopes and economic woes as virus spreads
Illinois mandated 'Stay-at-home' orders, nearby iowa didn't: here's what happened
Chirurgie-Ausbildung mit Roboter und Virtueller Realität
SARS-CoV-2 geht an die Nieren – welche therapeutischen Konsequenzen sind zu ziehen?
Largest study of its kind of women in labor finds nitrous oxide safe, side effects rare
the hunt for the antibody to treat COVID-19
New York's daily virus death toll falls below 100: governor
Virus cases drop to zero in China but surge in Latin America
World coronavirus cases top 5.5 million
Urlaub zuhause: Auch im Kräutergarten an Zecken denken
High-tech devices help NFL teams keep players safe, in shape
Hemmung zelleigenen Enzyms: Strategie für Entwicklung antiviraler Breitbandwirkstoffe
UK's COVID-19 study aims to vaccinate more than 10,000
Virus ignited in US no earlier than mid-January, study says
One minute electro-optical coronavirus test developed
'Knowing how' is in your brain
France revises down coronavirus death toll
Professor Christoph Keplinger bringt neue Robotergeneration nach Deutschland
Scientists fight online virus misinformation war
Forscher züchten kleine Lungen für die SARS-CoV-2-Forschung
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
UK buys 10 million antibody tests for care staff, patients
France to reopen cafes, end domestic travel limit
Hobbies may help defeating depression
Doctors should be cautious when using current warning system for patient's worsening health
Infopaket geschnürt: Von der Lupe bis zum Laser-Blindenstock
SARS-CoV-2: Möglicher protektiver Effekt durch Androgenentzug
As Ohio abortion regulations increased, disparities in care emerged
Neue Emmy Noether-Nachwuchsgruppe erforscht schwere Pilzinfektionen
Study quantifies China's chronic health burden for the first time
COVID-19: Herz-Kreislauf-Komplikationen auf der Spur
Researchers use old equations coupled with new methods to help decode the massively complex gut micr...
Neue Angiographie-Einheit erweitert Behandlungsmöglichkeiten deutlich
COVID-19 patients may have lower stroke rates than previously suggested
First-of-its-kind-study reveals that eating prior to cardiac catheterization is non-inferior to fast
The malaria parasite P. vivax can remain in the spleen upon expression of certain proteins
Europe's coronavirus cases top two million
New virus deaths in Spain fall to two-month low under 100
Tests expand on whether wearables could predict coronavirus
Häufiger Harndrang als Symptom von COVID-19?
Outcomes equal for AYA Hodgkin therapy at peds, adult centers
Study finds childhood cancer does not affect parental separation, divorce, and family planning in De...
Russia reports record coronavirus deaths, recoveries
Kinder und Jugendliche psychisch stark machen – Neues Infoportal geht ans Netz
Researchers develop high-performance cancer vaccine using novel microcapsules
Kritik am Patientendaten-Schutzgesetz - Biermann Medizin
Neue Erkenntnisse zu Hepatitis C bei Säuglingen könnte zu besseren Therapien führen

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Gjizë me Hudhra dhe Vaj Ulliri – Mrekulli Për Shijen dhe Shëndetin

Fri May 22 , 2020
Është një recetë e thjeshtë, shumë e shijshme dhe e mrekullueshme. Gjizën e përdorim në shumë receta të përditshme. Gjiza shkon mirë me speca të skuqur, me vezë, me spinaq, vaj ulliri e hudhër. Ajo është antipasta e preferuar e burrave që e shoqërojnë atë me raki. Vështirë të gjesh një […]